HK1059936A1 - Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use - Google Patents
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their useInfo
- Publication number
- HK1059936A1 HK1059936A1 HK04102849A HK04102849A HK1059936A1 HK 1059936 A1 HK1059936 A1 HK 1059936A1 HK 04102849 A HK04102849 A HK 04102849A HK 04102849 A HK04102849 A HK 04102849A HK 1059936 A1 HK1059936 A1 HK 1059936A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compounds
- production
- medicaments containing
- azetidinone derivatives
- diphenyl azetidinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10064402A DE10064402A1 (de) | 2000-12-21 | 2000-12-21 | Diphenylazetidinonderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
DE2001154520 DE10154520A1 (de) | 2001-11-07 | 2001-11-07 | Diphenylazetidinonderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
PCT/EP2001/014532 WO2002050068A1 (de) | 2000-12-21 | 2001-12-11 | Diphenylazetidinonderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1059936A1 true HK1059936A1 (en) | 2004-07-23 |
Family
ID=26008045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04102849A HK1059936A1 (en) | 2000-12-21 | 2004-04-22 | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
Country Status (24)
Country | Link |
---|---|
US (1) | US6498156B2 (pl) |
EP (1) | EP1345932B1 (pl) |
JP (1) | JP2004516293A (pl) |
KR (1) | KR20030061462A (pl) |
CN (1) | CN1222522C (pl) |
AR (1) | AR034282A1 (pl) |
AT (1) | ATE342899T1 (pl) |
AU (2) | AU2002219173B2 (pl) |
BR (1) | BR0116482A (pl) |
CA (1) | CA2431985A1 (pl) |
CZ (1) | CZ20031731A3 (pl) |
DE (1) | DE50111293D1 (pl) |
EE (1) | EE200300237A (pl) |
HK (1) | HK1059936A1 (pl) |
HR (1) | HRP20030499A2 (pl) |
HU (1) | HUP0401067A2 (pl) |
IL (1) | IL156552A0 (pl) |
MX (1) | MXPA03005018A (pl) |
NO (1) | NO20032733L (pl) |
NZ (1) | NZ526592A (pl) |
PL (1) | PL362173A1 (pl) |
SK (1) | SK7812003A3 (pl) |
WO (1) | WO2002050068A1 (pl) |
YU (1) | YU46903A (pl) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1345895T3 (da) * | 2000-12-21 | 2007-05-07 | Sanofi Aventis Deutschland | Hidtil ukendt diphenylazetidioner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse til behandling af lipidstofskifteforstyrrelser |
EP1785144A3 (en) * | 2001-01-26 | 2007-05-23 | Shering Corporation | Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
ATE374641T1 (de) * | 2001-01-26 | 2007-10-15 | Schering Corp | Kombinationen vom ppar-aktivator fenofibrat mit dem hemmer der sterol-absorption ezetimibe zur behandlung von kardiovaskulären indikationen |
EP1353694B1 (en) * | 2001-01-26 | 2007-12-19 | Schering Corporation | Combinations of ezetimibe with aspirine for treating vascular conditions |
SI1385548T1 (sl) * | 2001-01-26 | 2007-10-31 | Schering Corp | Kombinacije zaviralca(-ev) absorpcije sterola s kardiovaskularnim(-i) sredstvom(-i) za zdravljenje vaskularnih obolenj |
WO2002058685A2 (en) * | 2001-01-26 | 2002-08-01 | Schering Corporation | Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
MXPA04001328A (es) * | 2001-08-22 | 2004-05-05 | Aventis Pharma Gmbh | Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso. |
ATE345793T1 (de) * | 2001-09-21 | 2006-12-15 | Schering Corp | Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
US20030119808A1 (en) * | 2001-09-21 | 2003-06-26 | Schering Corporation | Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects |
US7053080B2 (en) * | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
US7671047B2 (en) | 2002-06-19 | 2010-03-02 | Sanofi-Aventis Deutschland Gmbh | Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
DE10227507A1 (de) * | 2002-06-19 | 2004-01-08 | Aventis Pharma Deutschland Gmbh | Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
US7176193B2 (en) | 2002-06-19 | 2007-02-13 | Sanofi-Aventis Deutschland Gmbh | Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
US7176194B2 (en) | 2002-06-19 | 2007-02-13 | Sanofi-Aventis Deutschland Gmbh | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
DE10227508A1 (de) * | 2002-06-19 | 2004-01-08 | Aventis Pharma Deutschland Gmbh | Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
GB0215579D0 (en) | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
EP1545479B1 (en) * | 2002-07-30 | 2010-10-27 | Karykion Inc. | Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors |
EP1601669B1 (en) * | 2003-03-07 | 2008-12-24 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
ES2311806T3 (es) | 2003-03-07 | 2009-02-16 | Schering Corporation | Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia. |
EP1626711A4 (en) * | 2003-05-09 | 2010-10-06 | Univ Pennsylvania | COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER |
EP1660456A2 (en) * | 2003-08-25 | 2006-05-31 | Microbia Inc. | Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones |
US8987322B2 (en) * | 2003-11-04 | 2015-03-24 | Circ Pharma Research And Development Limited | Pharmaceutical formulations for carrier-mediated transport statins and uses thereof |
EP1918000A2 (en) | 2003-11-05 | 2008-05-07 | Schering Corporation | Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
US7871998B2 (en) | 2003-12-23 | 2011-01-18 | Astrazeneca Ab | Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity |
EP1755573A1 (en) * | 2004-01-20 | 2007-02-28 | Panacea Biotec Ltd. | Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof |
WO2005087234A1 (en) | 2004-03-05 | 2005-09-22 | The Trustees Of The University Of Pennsylvania | Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects |
EP1807070A1 (en) * | 2004-09-29 | 2007-07-18 | Schering Corporation | Combinations of substituted azetidinones and cb1 antagonists |
WO2006047302A1 (en) * | 2004-10-21 | 2006-05-04 | Transtech Pharma, Inc. | Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
NZ555320A (en) | 2004-12-03 | 2010-11-26 | Schering Corp | Substituted piperazines as CB1 antagonists |
TW200726746A (en) * | 2005-05-06 | 2007-07-16 | Microbia Inc | Processes for production of 4-biphenylylazetidin-2-ones |
BRPI0611531A2 (pt) * | 2005-05-09 | 2010-09-21 | Microbia Inc | agentes de acoplamento de benzenofosfonato de organometal e método de geração de ligação carbono-carbono |
KR20080017345A (ko) * | 2005-05-11 | 2008-02-26 | 마이크로비아 인코포레이티드 | 페놀성 4-비페닐일아제티딘-2-온의 제조방법 |
CN101222950A (zh) * | 2005-05-25 | 2008-07-16 | 迈克罗比亚公司 | 制备4-(联苯基)氮杂环丁-2-酮膦酸的方法 |
US7635705B2 (en) * | 2005-06-20 | 2009-12-22 | Schering Corporation | Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists |
SA06270191B1 (ar) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
WO2007047880A2 (en) * | 2005-10-18 | 2007-04-26 | Aegerion Pharmaceuticals | Compositions for lowering serum cholesterol and/or triglycerides |
JP2009528266A (ja) * | 2006-01-18 | 2009-08-06 | シェーリング コーポレイション | カンナビノイド受容体修飾因子 |
AR060623A1 (es) | 2006-04-27 | 2008-07-02 | Astrazeneca Ab | Compuestos derivados de 2-azetidinona y un metodo de preparacion |
AU2007283113A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
WO2008030382A1 (en) * | 2006-09-05 | 2008-03-13 | Schering Corporation | Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
WO2008039829A2 (en) * | 2006-09-26 | 2008-04-03 | Ironwood Pharmaceuticals, Inc. | Diphenylheterocycle cholesterol absorption inhibitors |
DE102007002260A1 (de) * | 2007-01-16 | 2008-07-31 | Sanofi-Aventis | Verwendung von substituierten Pyranonsäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms |
US20100197564A1 (en) * | 2007-04-19 | 2010-08-05 | Schering Corporation | Diaryl morpholines as cb1 modulators |
EP2170846A2 (en) * | 2007-06-28 | 2010-04-07 | Intervet International BV | Substituted piperazines as cb1 antagonists |
EP2170847A2 (en) * | 2007-06-28 | 2010-04-07 | Intervet International BV | Substituted piperazines as cb1 antagonists |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007054497B3 (de) * | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
US20090312302A1 (en) * | 2008-06-17 | 2009-12-17 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating nonalcoholic fatty liver disease-associated disorders |
UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
EP2403848A1 (en) | 2009-03-06 | 2012-01-11 | Lipideon Biotechnology AG | Pharmaceutical hypocholesterolemic compositions |
CN101993403B (zh) | 2009-08-11 | 2012-07-11 | 浙江海正药业股份有限公司 | 氮杂环丁酮类化合物及医药应用 |
CA2771278A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
CN102746249B (zh) * | 2012-07-07 | 2013-12-25 | 山东诚创医药技术开发有限公司 | 一种依折麦布中间体的纯化精制方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
MX9606319A (es) * | 1994-06-20 | 1997-05-31 | Schering Corp | Compuestos de acetidinonas sustituidas utiles como agentes hipocolesterolemicos. |
US5994391A (en) * | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
WO1996008484A1 (en) * | 1994-09-13 | 1996-03-21 | Monsanto Company | Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
US5656624A (en) * | 1994-12-21 | 1997-08-12 | Schering Corporation | 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
US5756470A (en) | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
-
2000
- 2000-12-11 IL IL15655200A patent/IL156552A0/xx unknown
-
2001
- 2001-12-11 SK SK781-2003A patent/SK7812003A3/sk unknown
- 2001-12-11 EE EEP200300237A patent/EE200300237A/xx unknown
- 2001-12-11 KR KR10-2003-7008330A patent/KR20030061462A/ko not_active Application Discontinuation
- 2001-12-11 WO PCT/EP2001/014532 patent/WO2002050068A1/de not_active Application Discontinuation
- 2001-12-11 MX MXPA03005018A patent/MXPA03005018A/es active IP Right Grant
- 2001-12-11 AT AT01271371T patent/ATE342899T1/de not_active IP Right Cessation
- 2001-12-11 AU AU2002219173A patent/AU2002219173B2/en not_active Expired - Fee Related
- 2001-12-11 DE DE50111293T patent/DE50111293D1/de not_active Expired - Lifetime
- 2001-12-11 JP JP2002551564A patent/JP2004516293A/ja not_active Abandoned
- 2001-12-11 PL PL01362173A patent/PL362173A1/pl not_active Application Discontinuation
- 2001-12-11 CZ CZ20031731A patent/CZ20031731A3/cs unknown
- 2001-12-11 AU AU1917302A patent/AU1917302A/xx active Pending
- 2001-12-11 EP EP01271371A patent/EP1345932B1/de not_active Expired - Lifetime
- 2001-12-11 HU HU0401067A patent/HUP0401067A2/hu unknown
- 2001-12-11 YU YU46903A patent/YU46903A/sh unknown
- 2001-12-11 BR BR0116482-1A patent/BR0116482A/pt not_active IP Right Cessation
- 2001-12-11 CA CA002431985A patent/CA2431985A1/en not_active Abandoned
- 2001-12-11 NZ NZ526592A patent/NZ526592A/en unknown
- 2001-12-11 CN CNB018210449A patent/CN1222522C/zh not_active Expired - Fee Related
- 2001-12-19 US US10/021,028 patent/US6498156B2/en not_active Expired - Lifetime
- 2001-12-19 AR ARP010105906A patent/AR034282A1/es unknown
-
2003
- 2003-06-16 NO NO20032733A patent/NO20032733L/no not_active Application Discontinuation
- 2003-06-18 HR HR20030499A patent/HRP20030499A2/hr not_active Application Discontinuation
-
2004
- 2004-04-22 HK HK04102849A patent/HK1059936A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU1917302A (en) | 2002-07-01 |
ATE342899T1 (de) | 2006-11-15 |
MXPA03005018A (es) | 2003-09-25 |
CA2431985A1 (en) | 2002-06-27 |
NO20032733D0 (no) | 2003-06-16 |
HUP0401067A2 (hu) | 2004-09-28 |
HRP20030499A2 (en) | 2005-04-30 |
CZ20031731A3 (cs) | 2003-09-17 |
AR034282A1 (es) | 2004-02-18 |
US6498156B2 (en) | 2002-12-24 |
EE200300237A (et) | 2003-08-15 |
NZ526592A (en) | 2004-11-26 |
EP1345932B1 (de) | 2006-10-18 |
WO2002050068A1 (de) | 2002-06-27 |
BR0116482A (pt) | 2004-02-03 |
CN1481381A (zh) | 2004-03-10 |
NO20032733L (no) | 2003-08-14 |
DE50111293D1 (de) | 2006-11-30 |
JP2004516293A (ja) | 2004-06-03 |
SK7812003A3 (en) | 2004-01-08 |
US20020128252A1 (en) | 2002-09-12 |
PL362173A1 (pl) | 2004-10-18 |
EP1345932A1 (de) | 2003-09-24 |
KR20030061462A (ko) | 2003-07-18 |
YU46903A (sh) | 2006-05-25 |
CN1222522C (zh) | 2005-10-12 |
IL156552A0 (en) | 2004-01-04 |
AU2002219173B2 (en) | 2006-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL156552A0 (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use | |
HRP20030501A2 (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use | |
AU2002219173A1 (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use | |
HUS1400005I1 (hu) | Kinazolinszármazékok, elõállításuk, alkalmazásuk és ezeket tartalmazó gyógyszerek | |
ZA200102588B (en) | Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use. | |
AU8769401A (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
AU2001295481A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
HK1044769A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof. | |
AU2001287694A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
HUP0401081A3 (en) | Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and their use | |
MXPA03000873A (es) | Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos. | |
HK1081965A1 (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
IL150377A0 (en) | Substituted piperidines, medicaments containing these compounds, and methods for the production thereof | |
MXPA03001510A (es) | Heterociclos biciclicos, medicamentos que contiene estos compuestos, su empleo y procedimientos para su preparacion. | |
HU0001178D0 (en) | New propene-carbon acid-amidoxim derivatives, process for their production and medicaments containing the same | |
SI1560826T1 (sl) | Spojine piridopirimidinona, postopek za njihovo pripravo in farmacevtski sestavki, ki te vsebujejo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20091211 |